期刊文献+

脉冲温控射频治疗晚期胰腺癌顽固性疼痛的疗效观察 被引量:4

OBSERVATION OF THERAPEUTIC EFFECT ABOUT UNRESECTABLE PANCREATIC CARCINOMA WITH INTRACTABLE PAIN BY PULSED-THERMOCONTROL-REDIOFREQUENCY
下载PDF
导出
摘要 目的:探讨脉冲温控射频治疗晚期胰腺癌顽固性疼痛的疗效。方法:对46例伴有顽固性疼痛的晚期胰腺癌病人给予脉冲温控射频治疗,观察疼痛缓解、KPS评分以及并发症情况。结果:所有病人治疗后疼痛减轻,VAS评分明显减少(P<0.05)。精神、睡眠、营养状况等显著改善,KPS评分较术前明显增高(P<0.05)。少数病人(8.7%)出现轻度消化道并发症,经对症治疗后治愈。结论:脉冲温控射频是一种有效、安全的治疗晚期胰腺癌顽固性疼痛的手段,并能有效地改善病人生存质量。 Objective: To explore the therapeutic effect of intractable pancreatic carcinomatous pain by pulsed-thermocontrol-radiofrequency. Methods: 46 cases of unresectable pancreatic carcinoma with intractable pain were treated by pulsed-thermocontrol-radiofrequency. Pain-relief, KPS and complications after treatment were observed. Results: Follow up ranged from 0 to 90 days observation showed that the intractable pain in all patients was controlled after the therapy. VAS was decreased obviously (P 〈 0. 05 ). Spirit condition, sleeping and nutritional state were improved significantly, KPS was increased obvi- ously(P 〈0.05). There were a few cases(8.7% ) occurrence minor alimentary complications, and all healed by conservative treatments. Conclusion: Pulsed-thermocontrol-radiofrequency is a method with safe and good effective and less complications for the treatment of intractable pancreatic carcinomatous pain, and it can improve life quality of patients efficiently.
出处 《中国疼痛医学杂志》 CAS CSCD 2009年第4期210-213,共4页 Chinese Journal of Pain Medicine
关键词 胰腺癌 脉冲温度控制射频 疼痛 Pancreatic carcinoma Pulsed-thermocontrol-radiofrequency Pain
  • 相关文献

参考文献3

二级参考文献16

  • 1[1]Burris HA 3rd,Moore MJ,Andersen J,Green MR,Rothenberg ML,Modiano MR,Cripps MC,Portenoy RK,Storniolo AM,Tarassoff P,Nelson R,Dorr FA,Stephens CD,Von Hoff DD.Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer:a randomized trial.J Clin Oncol 1997; 15:2403-2413
  • 2[2]Heinemann V.Gemcitabine in the treatment of advanced pancreatic cancer:a comparative analysis of randomized trials.Semin Oncol 2002; 29:9-16
  • 3[3]Moore MJ,Goldstein D,Hamm J,Finger A,Hecht J,Gallinger S,Au H,Ding K,Christy-Bittel J,Parulekar W.Erlotinib plus gemcitabine compared to gemcitabine alone in patients with advanced pancreatic cancer.A phase Ⅲ trial of the National Cancer Institute of Canada Clinicals trials group[NCIC-CTG].Proc Am Soc Clin Oncol 2005; 23:1
  • 4[4]Cunningham D,Chau I,Stocken D,Davies C,Dunn J,Valle J,Smith D,Steward W,Harper P,Neoptolemos J.Phase Ⅲ randomised comparison of gemcitabine (GEM) versus gemcitabine plus capecitabine (GEM-CAP) in patients with advanced pancreatic cancer.Eur J Cancer Suppl 2005; 3:11
  • 5[5]Saad ED,Machado MC,Wajsbrot D,Abramoff R,Hoff PM,Tabacof J,Katz A,Simon SD,Gansl RC.Pretreatment CA 19-9 level as a prognostic factor in patients with advanced pancreatic cancer treated with gemcitabine.Int J Gastrointest Cancer 2002; 32:35-41
  • 6[6]Maisey NR,Norman AR,Hill A,Massey A,Oates J,Cunningham D.CA19-9 as a prognostic factor in inoperable pancreatic cancer:the implication for clinical trials.Br J Cancer 2005; 93:740-743
  • 7[7]Sawaki A,Kanemitsu Y,Mizuno N,Takahashi K,Nakamura T,Ioka T,Tanaka S,Nakaizumi A,Salem AA,Ueda R,Yamao K.Practical prognostic index for patients with metastatic pancreatic cancer treated with gemcitabine.J Gastroenterol Hepatol 2006; Epub ahead of print,DOI:10.1111/j.1440-1746.2006.04734.x
  • 8[8]Ebrahimi B,Tucker SL,Li D,Abbruzzese JL,Kurzrock R.Cytokines in pancreatic carcinoma:correlation with phenotypic characteristics and prognosis.Cancer 2004; 101:2727-2736
  • 9[9]Van Cutsem E,van de Velde H,Karasek P,Oettle H,Vervenne WL,Szawlowski A,Schoffski P,Post S,Verslype C,Neumann H,Safran H,Humblet Y,Perez Ruixo J,Ma Y,Von Hoff D.Phase Ⅲ trial of gemcitabine plus tipifarnib compared with gemcitabine plus placebo in advanced pancreatic cancer.J Clin Oncol 2004; 22:1430-1438
  • 10[10]Ishii H,Okada S,Nose H,Yoshimori M,Aoki K,Okusaka T.Prognostic factors in patients with advanced pancreatic cancer treated with systemic chemotherapy.Pancreas 1996; 12:267-271

共引文献19

同被引文献71

引证文献4

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部